Occurrence and characteristics of patients with de novo advanced breast cancer according to patient and tumor characteristics – A retrospective analysis of a real world registry-Reference-Cited by-同舟云学术

Occurrence and characteristics of patients with de novo advanced breast cancer according to patient and tumor characteristics – A retrospective analysis of a real world registry

Published:2022-09 Issue: Volume:172 Page:13-21
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Müller Volkmar,Hein Alexander^ORCID,Hartkopf Andreas D.,Fasching Peter A.^ORCID,Kolberg Hans-Christian,Hadji Peyman,Tesch Hans,Häberle Lothar,Ettl Johannes,Lüftner Diana,Wallwiener Markus,Beckmann Matthias W.,Schneeweiss Andreas,Belleville Erik,Uhrig Sabrina,Wimberger Pauline^ORCID,Hielscher Carsten,Meyer Julia,Wurmthaler Lena A.,Kurbacher Christian M.,Wuerstlein Rachel,Untch Michael,Janni Wolfgang^ORCID,Taran Florin-Andrei,Lux Michael P.^ORCID,Wallwiener Diethelm,Brucker Sara Y.^ORCID,Fehm Tanja N.,Michel Laura L.^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference20 articles.

1. Survival differences among women with de novo stage IV and relapsed breast cancer;Dawood;Ann Oncol,2010

2. Comparison of outcomes between women with de novo stage IV and relapsed breast cancer;Kitagawa;J Nippon Med Sch,2014

3. Clinicopathologic factors associated with de novo metastatic breast cancer;Shen;Pathol Res Pract,2016

4. Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed;den Brok;Breast Cancer Res Treat,2017

5. De novo metastasis in breast cancer: occurrence and overall survival stratified by molecular subtype;Press;Clin Exp Metastasis,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. De novo versus recurrent metastatic breast cancer affects the extent of brain metastases;Journal of Neuro-Oncology;2024-06-12

2. Update Breast Cancer 2024 Part 1 – Expert Opinion on Advanced Breast Cancer;Geburtshilfe und Frauenheilkunde;2024-05-29

3. Case report: An exceptional responder of low-dose continuous 5-FU in a patient with de-novo stage IV triple-negative breast cancer with liver and bone marrow failure;Frontiers in Oncology;2024-01-15

4. Standard-of-Care Treatment for HER2+ Metastatic Breast Cancer and Emerging Therapeutic Options;Breast Cancer: Basic and Clinical Research;2024-01